July
2023
Nanion launches AtlaZ
AtlaZ brings in vitro cell analytics to a new dimension. It is an advanced system designed for quantitative live-cell analysis. It provides researchers with the capability to investigate various cellular aspects label-free and
in real time.
{{current_slide_index}}/{{total_slide_count}}
July 2023
January
2022
Nanion celebrates 20 years of innovation
Over the course of 20 years, we have stayed true to our passion for continuous improvement and constant growth. We are still commited to providing the best possible support for our customers.
{{current_slide_index}}/{{total_slide_count}}
Jan 2022
July
2021
Launch of the SyncroPatch 384
Newest generation automated patch clamp system has been introduced to the market. Whether you are screening large compound libraries or investigating complex biophysical properties of ion channels, the SyncroPatch can do it all due to its high flexibility.
{{current_slide_index}}/{{total_slide_count}}
July 2021
June
2021
Introducing Orbit 16 TC
The Orbit 16 TC platform takes the pain out of bilayer painting, with 16 recording channels and temperature control.
{{current_slide_index}}/{{total_slide_count}}
June 2021
September
2019
Big expansion of Nanion´s product portfolio
We were very busy with the launch of three major additions to our product portfolio: FLEXcyte 96 for contractile force measurements, Dynamite8 for automated dynamic clamp recordings and Port-a-Patch mini for cost effective and fast patch clamping. We enjoyed showcasing them during the SPS meeting in Barcelona.
{{current_slide_index}}/{{total_slide_count}}
Sep 2019
June
2017
Nanion expands business to Japan
Nanion KK was founded in 2017 within the prestigious Tokyo Women´s Medical University - Waseda University Joint Institution for Advanced Biomedical Scieneces (TWins).
{{current_slide_index}}/{{total_slide_count}}
Jun 2017
February
2017
Launch of SURFE2R 96SE
The SURFE2R 96SE is the first instrument on the market featuring the solid supported membrane (SSM) technology for the robust and simple screening of membrane transporters and pumps in a high throughput manner.
{{current_slide_index}}/{{total_slide_count}}
Feb 2017
June
2016
Nanion opens site in Denmark
The new fully equipped facility within Copenhagen University opened its doors for scientific collaborations, assay development support and product demonstrations.
{{current_slide_index}}/{{total_slide_count}}
Jun 2016
September
2014
Launch of CardioExcyte 96
In 2014, we launched the CardioExcyte 96, equipped with contractility and field potential technology, to analyze iPSC-derived cardiomyocyte networks for drug safety assessment. It also enables cell monitoring for cell viability assays on a diverse range of cells types (e. g. hepatocytes) for toxicity screening.
{{current_slide_index}}/{{total_slide_count}}
Sept 2014
September
2014
"Deutscher Zukunftspreis" nomination and more product releases
Nanion was one of 3 companies nominated for the prestigious prize for technology and innovation awarded by the German president. In the same year, Nanion launched the CardioExcyte 96 for contractility and electrophysiology recordings of cardiomyocytes and the Orbit mini for bilayer measurements.
{{current_slide_index}}/{{total_slide_count}}
Sept 2014
September
2014
Launch of Orbit mini
Orbit 16 got a little brother! In 2014 we introduced the Orbit mini, a miniaturized bilayer workstation enabling the recording of 4 artificial lipid bilayers simultaneously.
{{current_slide_index}}/{{total_slide_count}}
Sept 2014
September
2013
APC meets HTS Nanion starts shipping its high throughput screening instrument, the SyncroPatch 384PE.
{{current_slide_index}}/{{total_slide_count}}
Sept 2013
February
2012
Membrane biophysics benefits The Orbit 16 for recording 16 bilayers in parallel was launched and Nanion acquired the SURFE²R Technology for Transporter Protein Analysis. {{current_slide_index}}/{{total_slide_count}}
Feb 2012 July
2009
Winner of the “Deutscher Gründerpreis” and STEP Award
The Deutscher Gründerpreis is the most prestigious award for outstanding entrepreneurs in Germany. In the same year, Nanion competed with 120 companies to be awarded the STEP Award 2009 and established Nanion Inc. in New Jersey, USA.
{{current_slide_index}}/{{total_slide_count}}
July 2009
January
2008
First "User publication" in Nature The first Patchliner user publication focus on TRC5 ion channel and its function in rheumatoid arthritis and it was published in high impact journal, Nature.
{{current_slide_index}}/{{total_slide_count}}
Jan 2008
June
2007
Vesicle Prep Pro launched Nanion launched the Vesicle Prep Pro for the quick and easy production of giant vesicles (GUVs).
{{current_slide_index}}/{{total_slide_count}}
Jun 2007
July
2006
Patchliner introduced into the market The Patchliner was the second patch clamp instrument launched by Nanion. It was the first fully automated patch clamp device from Nanion recording from multiple cells in parallel.
{{current_slide_index}}/{{total_slide_count}}
Jul 2006
May
2003
Nanion launches its first patch clamp instrument The Port-a-Patch, the world’s smallest patch clamp rig, was introduced onto the market in 2003. {{current_slide_index}}/{{total_slide_count}}
May 2003
July
2002
Nanion was founded "In 2002, we published what I would consider to be my most important scientific work: the development and successful implementation of the planar patch clamp approach. This work was not only the most important of my scientific achievements, but also the basis for starting Nanion Technologies in the same year, with Michael George as CTO. " - Niels Fertig, CEO {{current_slide_index}}/{{total_slide_count}}
July 2002
